Schusdziarra V, Classen M
Department of Internal Medicine II, Technical University of Munich, Germany.
Z Gastroenterol. 1988 Dec;26(12):762-6.
In the present study we examined the effect of Thr28 Nle31-CCK 25-33 (CCK-9) on pancreatic exocrine function in man. In subjects without pancreatic disease CCK-9 together with i.v. secretin (0.5 CU/kg/h) elicited a maximal stimulation of amylase output at a dose of 10 pmol/kg/h while trypsin and chymotrypsin were stimulated maximally at a dose of 30 pmol/kg/h. Higher doses of 60 and 100 pmol/kg/h had no additional effects. Lipase secretion was stimulated by secretin alone with no additional effect of CCK-9. During all doses of CCK-9 no side effects were observed. In patients with chronic pancreatitis a dose of 30 pmol/kg/h was also sufficient to obtain maximal enzyme output. In conclusion this derivative of CCK can be considered as a potent and useful alternative to amphibian caerulein in direct pancreatic function tests.
在本研究中,我们检测了苏氨酸28 - 异亮氨酸31 - 胆囊收缩素25 - 33(CCK - 9)对人体胰腺外分泌功能的影响。在无胰腺疾病的受试者中,CCK - 9与静脉注射的促胰液素(0.5 CU/kg/h)联合使用时,剂量为10 pmol/kg/h时可引起淀粉酶分泌的最大刺激,而剂量为30 pmol/kg/h时胰蛋白酶和糜蛋白酶受到最大刺激。60和100 pmol/kg/h的更高剂量无额外作用。脂肪酶分泌仅由促胰液素刺激,CCK - 9无额外作用。在所有CCK - 9剂量下均未观察到副作用。在慢性胰腺炎患者中,30 pmol/kg/h的剂量也足以获得最大酶分泌量。总之,在直接胰腺功能测试中,这种CCK衍生物可被视为蛙皮素的一种有效且有用的替代物。